(Q81795147)

English

Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients

scientific article published on 15 August 2008

Statements

Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit